Clinical Trial Update: Effect of Pirfenidone on TA Fibrosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating pirfenidone for fibrosis in Takayasu arteritis, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Takayasu Arteritis | Phase 4 | Status: NOT_YET_RECRUITING